#-supreme-cellcarta-differentiators-5-450{items-data:[{"text":"Deep Scientific Rigor"},{"text":"Integrated Multi-Modal Capabilities"},{"text":"Global Execution"},{"text":"Complex Biomarker Expertise"},{"text":"High-Touch Collaboration"}]}#-supreme-cellcarta-overview-3-450{stats-data:[{"number":"20+","label":"Years of expertise"},{"number":"8","label":"Global labs"},{"number":"750+","label":"Experts globally"}]}#-supreme-cellcarta-service-cards-4-450{cards-data:[{"image":"https://cellcarta.supremeclients.com/wp-content/uploads/2026/07/21-Biomarker-Solutions-Hero.jpg","image_alt":"CellCarta scientist developing multi-platform biomarker strategies across discovery and clinical development stages","title":"Biomarker","description":"Multi-platform biomarker strategies from discovery through clinical development.","link1_label":"Biomarker","link1_url":"/capabilities/biomarkers/","link2_label":"","link2_url":"","link3_label":"","link3_url":"","link4_label":"","link4_url":"","link5_label":"","link5_url":""},{"image":"https://cellcarta.supremeclients.com/wp-content/uploads/2026/06/Genomics-Services-449.jpg","image_alt":"Genomics laboratory scientist performing molecular platform analysis on clinical samples for biomarker reporting","title":"Genomics","description":"Proven and emerging molecular platforms for clinical sample analysis and reporting.","link1_label":"Sequencing Services","link1_url":"/capabilities/genomics/sequencing-services/","link2_label":"Digital PCR (dPCR)","link2_url":"/capabilities/genomics/digital-pcr-services/","link3_label":"Quantitative PCR (qPCR)","link3_url":"/capabilities/genomics/qpcr-services/","link4_label":"Assays by Mutations","link4_url":"/capabilities/genomics/assays-by-mutations/","link5_label":"","link5_url":""},{"image":"https://cellcarta.supremeclients.com/wp-content/uploads/2026/07/Histopathology-Services-hero-34.jpg","image_alt":"Histopathologist performing multiplexed tissue analysis with AI-powered image analysis at CellCarta","title":"Histopathology","description":"Multiplexed tissue analysis with in-house pathologists and AI-powered image analysis.","link1_label":"Digital Pathology","link1_url":"/capabilities/histopathology/digital-pathology/","link2_label":"IF and IHC","link2_url":"/capabilities/histopathology/if-ihc/","link3_label":"ISH","link3_url":"/capabilities/histopathology/ish/","link4_label":"Spatial Biology","link4_url":"/capabilities/histopathology/spatial-biology/","link5_label":"","link5_url":""},{"image":"https://cellcarta.supremeclients.com/wp-content/uploads/2026/06/19-IImmune-Monitoring-hero.jpg","image_alt":"Scientist conducting multiplex immune response monitoring assays supporting clinical trial biomarker programs","title":"Immune Monitoring","description":"Multiplex assays for immune response monitoring across the clinical trial continuum.","link1_label":"Basophil Activation Test (BAT)","link1_url":"/capabilities/immune-monitoring/basophil-activation-test/","link2_label":"Cell Enumeration","link2_url":"/capabilities/immune-monitoring/cell-enumeration/","link3_label":"Cell Proliferation","link3_url":"/capabilities/immune-monitoring/cell-proliferation/","link4_label":"Cellular Phenotyping","link4_url":"/capabilities/immune-monitoring/cellular-phenotyping/","link5_label":"","link5_url":""},{"image":"https://cellcarta.supremeclients.com/wp-content/uploads/2026/06/Immunoassay-Services-hero-9.jpg","image_alt":"CellCarta scientist operating validated immunoassay platforms for precise biomarker quantification and clinical testing","title":"Immunoassay Platform","description":"Validated immunoassay platforms for precise biomarker quantification and clinical testing.","link1_label":"Ella™","link1_url":"/capabilities/immunoassay-services/ella-multiplexing-elisa/","link2_label":"Olink PEA","link2_url":"/capabilities/immunoassay-services/olink-pea-technology/","link3_label":"FluoroSpot and ELIspot","link3_url":"/capabilities/immunoassay-services/fluorospot-elispot/","link4_label":"Hybrid LBA/LC-MS","link4_url":"/capabilities/immunoassay-services/hybrid-lba-lc-ms/","link5_label":"","link5_url":""},{"image":"https://cellcarta.supremeclients.com/wp-content/uploads/2026/07/Proteomics-Services-Hero-36.jpg","image_alt":"Mass spectrometry scientist running fully integrated MS platforms for large-scale discovery and bioanalytical testing","title":"Proteomics","description":"Fully integrated MS platforms for large-scale discovery and bioanalytical testing.","link1_label":"Unbiased Discovery","link1_url":"/capabilities/proteomics/unbiased-discovery/","link2_label":"Biomarker Quantification","link2_url":"/capabilities/proteomics/biomarker-quantification/","link3_label":"","link3_url":"","link4_label":"","link4_url":"","link5_label":"","link5_url":""}]}#-supreme-cellcarta-testimonials-6-450{items-data:[{"image":"","image_alt":"","quote":"Lorem ipsum dolor sit amet,consectetur adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes. Cum sociis natoque penatibus et magnis dis parturient montes.","author_name":"John Seer","author_role":"Founder,President","author_company":"Company Name"},{"image":"","image_alt":"","quote":"Lorem ipsum dolor sit amet,consectetur adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes. Cum sociis natoque penatibus et magnis dis parturient montes.","author_name":"John Seer","author_role":"Founder,President","author_company":"Company Name"},{"image":"","image_alt":"","quote":"Lorem ipsum dolor sit amet,consectetur adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes. Cum sociis natoque penatibus et magnis dis parturient montes.","author_name":"John Seer","author_role":"Founder,President","author_company":"Company Name"}]}